Thermo Fisher Scientific Inc Stock in Q2 2019 Driven by Institutional Investors

Thermo Fisher Scientific Inc. (NYSE:TMO) Logo

Sentiment for Thermo Fisher Scientific Inc (NYSE:TMO)

Thermo Fisher Scientific Inc (NYSE:TMO) institutional sentiment increased to 1.06 in Q2 2019. Its up 0.10, from 0.96 in 2019Q1. The ratio has increased, as 494 funds increased and started new holdings, while 464 cut down and sold stock positions in Thermo Fisher Scientific Inc. The funds in our partner’s database now possess: 338.08 million shares, up from 337.12 million shares in 2019Q1. Also, the number of funds holding Thermo Fisher Scientific Inc in their top 10 holdings increased from 106 to 107 for an increase of 1. Sold All: 35 Reduced: 429 Increased: 373 New Position: 121.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. The company has market cap of $119.20 billion. The Company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. It has a 33.99 P/E ratio. The Company’s Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

The stock increased 0.91% or $2.68 during the last trading session, reaching $297.65. About 909,529 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 20.35% since September 13, 2018 and is uptrending. It has outperformed by 20.35% the S&P500.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on October, 23. They expect $2.88 earnings per share, up 9.92 % or $0.26 from last year’s $2.62 per share. TMO’s profit will be $1.15B for 25.84 P/E if the $2.88 EPS becomes a reality. After $3.04 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts -5.26 % negative EPS growth.

Cryder Capital Partners Llp holds 17.4% of its portfolio in Thermo Fisher Scientific Inc. for 400,650 shares. Caledonia Investments Plc owns 148,917 shares or 12.22% of their US portfolio. Moreover, Veritas Investment Management Llp has 10.24% invested in the company for 389,345 shares. The Massachusetts-based Athena Capital Advisors Llc has invested 8.37% in the stock. Veritas Investment Management (Uk) Ltd, a United Kingdom-based fund reported 96,457 shares.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Ratings analysis reveals 100% of Thermo Fisher’s analysts are positive. Out of 7 Wall Street analysts rating Thermo Fisher, 7 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $288 while the high is $32100. The stock’s average target of $307 is 3.14% above today’s ($297.65) share price. TMO was included in 13 notes of analysts from March 18, 2019. Deutsche Bank maintained the stock with “Buy” rating in Friday, March 22 report. The firm has “Buy” rating by UBS given on Monday, March 25. The firm has “Outperform” rating given on Tuesday, March 26 by Robert W. Baird. The stock has “Buy” rating by Barclays Capital on Monday, March 18. The stock has “Buy” rating by Argus Research on Wednesday, May 1. As per Thursday, May 23, the company rating was maintained by UBS. BTIG Research maintained it with “Buy” rating and $310 target in Tuesday, March 26 report. As per Tuesday, July 16, the company rating was downgraded by Needham. The company was maintained on Thursday, July 25 by Needham.

More notable recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: which released: “Medtronic, Other Medtech Providers Could Face Additional Tariffs – Yahoo Finance” on September 03, 2019, also with their article: “Thermo Fisher Scientific Elects New Director to Board – PRNewswire” published on September 05, 2019, published: “Thermo Fisher to develop companion diagnostic for Lilly’s selpercatinib – Seeking Alpha” on September 09, 2019. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) were released by: and their article: “Thermo Fisher Scientific (TMO), Danaher (DHR) Said Among Firms Eyeing KKR’s (KKR) LGC – Bloomberg (Earlier) –” published on September 06, 2019 as well as‘s news article titled: “At US$292, Is Thermo Fisher Scientific Inc. (NYSE:TMO) Worth Looking At Closely? – Yahoo Finance” with publication date: June 27, 2019.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.